India to Brazil: Cytarabine Export Trade Route

The India to Brazil Cytarabine corridor is one of India's established pharmaceutical export routes, with 39 shipments documented worth a combined $1.3M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 84% of all export value, reflecting the consolidated nature of India's cytarabine manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $34.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with cytarabine's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 31.7%, placing it at rank #14 among India's top cytarabine export destinations globally.

On the import side, key buyers of Indian cytarabine in Brazil include ACCORD FARMACUTICA LTDA, ACCORD FARMACUTICA LTDA., ACCORD FARMACUTICA LIMITEDA and 4 others. ACCORD FARMACUTICA LTDA is the single largest importer with 13 shipments valued at $460.3K USD.

India's cytarabine exports to Brazil are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 32 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $34.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma drugs medi cytarabine inj bp 1000mg 10 ml vial as per invoice and pharma drugs and medi cytarabine inj bp1000mg/10 ml vial as per invnos, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ACCORD FARMACUTICA LTDA is the largest importer with 13 shipments worth $460.3K USD — representing 34% of all cytarabine imports from India on this route. A total of 7 buyers are active on this corridor.